Oregon s PDMP: An epidemiological assist tool

Size: px
Start display at page:

Download "Oregon s PDMP: An epidemiological assist tool"

Transcription

1 Oregon s PDMP: An epidemiological assist tool Todd Beran Center for Prevention and Health Promotion Oregon Health Authority PDMP TTAC Webinar February 13,

2 Acknowledgements Lisa Millet, MSH, Section Manager, Injury & Violence Prevention Prevention Dagan Wright, PhD, MSPH, Lead Research Analyst, Public Health Division Heidi Murphy, MPH, Research Analyst, Public Health Division Bruce Gutelius, MD, MPH, Administrator Center for Prevention & Health Promotion Katrina Hedberg, MD, MPH, Chief Science Officer, Public Health Division Data workgroup for the PDMP Gary Schnabel, RN, RPh, Executive Director, Board of Pharmacy Brad Anderson, MD, Kaiser Permanente, Chief Department of Addiction Medicine Wayne Wakeland, PhD, Associate Professor, Systems Science Program, Portland State University Ted Williams, Clinical Pharmacist, Oregon State University/Oregon Health Sciences University College of Pharmacy Drug Use Research & Management Group Rick Deyo, MD, Professor, Department of Family Medicine, Oregon Health Sciences University Sally Logan, RPh, Kaiser Permanente, Outpatient Pharmacy Quality Coordinator 2

3 Objectives Recognize the complex issue of overdose Explain the purpose of Oregon s PDMP data reports Identify how PDMPs can be helpful in addressing overdose from a public health framework Describe PDMP next steps and ongoing work 3

4 Think about how many Oregonians have medically necessary treatment with controlled substances 760,000 live with chronic pain (20%) 100,000+ are treated for injury in ED annually 213,000 have surgical visits each year (5.5%) 8,000 die of cancer 20,000 new cases of cancer each year Uncounted dental encounters to reduce pain 500,000 have an anxiety disorder (18%) Source: Statewide PDMP Data Report, Oct to Mar. 31,

5 450 Unintentional drug poisoning deaths by year and drug type, Oregon, 2000 to 2011 deaths Death rate per 100,000 population Cocaine Heroin Prescription opioids Rate of drug poisoning Year Source: Oregon Center for Health Statistics Vital Records 5

6 Percentage of prescription opioid-related deaths by age group, Oregon, Percentage of total deaths Age Group Source: Oregon Center for Health Statistics Vital Records 6

7 Overdose death rate by drug type per 100,000 OR, Note: a person can have more than 1 contributing drug related to their death Heroin Prescrip. Opioid Drugs 4.0 Methadone 3.0 Benzodiazepines 2.0 Antiepileptic, sedative-hypnotic, antidepressant 1.0 Cocaine Methamphetamines and other psycholstim Source: Oregon Center for Health Statistics Vital Records

8 Overdose hospitalization rate by primary underlying drug per 100,000, OR, Psychostimulants with abuse potential 12.0 Other,unspecified drugs Heroin 6.0 Prescrip opioids 4.0 Benzodiazepines 2.0 Methadone Antidepressants,etc,psychotropic drugs NEC Source: Oregon Hospital Discharge Index

9 Frequency and percent of unintentional drug overdose deaths from more than one drug, OR, , 9% 83, 4% 24, 1% 3, 0% 4 out of 10 deaths have more than 1 drug listed as an underlying cause 1 476, 24% , 62% Source: Oregon Center for Health Statistics Vital Records

10 12 Overdose death rate by drug type per 100,000 among females by age group, OR, Note: a person can have more than 1 contributing drug related to their death Heroin Methadone Antiepileptic, sedative-hypnotic, antidepressant, other psychotropic Methamphetamines and other psychostimulants Prescrip opioids Other and unspecified narcotics Benzodiazepines Only unspecified drug mentioned Source: Oregon Center for Health Statistics Vital Records

11 10 Overdose death rate by drug type per 100,000 among males by age group, OR, Note: a person can have more than 1 contributing drug related to their death Heroin Methadone Antiepileptic, sedative-hypnotic, antidepressant, other psychotropic Methamphetamines and other psychostimulants Prescrip opioids Other and unspecified narcotics Benzodiazepines Only unspecified drug mentioned Source: Oregon Center for Health Statistics Vital Records

12 Opioid overdose: factors among decedents Washington: Medicaid population at high risk times higher risk of death 1 Utah: 40% of decedents had history of substance abuse; 49% diagnosed with mental illness 2 1 Centers for Disease Control and Prevention (CDC). Overdose deaths involving prescription opioids among Medicaid enrollees - Washington, MMWR Morb Mortal Wkly Rep Oct 30;58(42): Utah Drug Overdose Mortality Project: 12

13 Who is most at risk? A CDC policy impact report cites the following indicators for people at highest risk for prescription painkiller overdose: Take high doses of prescription painkillers Have low incomes Live in rural areas Have a history of mental illness Have a history of substance misuse are at highest risk for overdosing Source: Policy Impact: Prescription Painkiller Overdoses: 13

14 Overdose data recap Many medically necessities for use of controlled substances 53% of drug overdoses in Oregon associated with prescription opioids Over 40% of deceased have multiple drugs on board Patients with history of substance abuse and/or mental illness have greatly increased risk for overdose Medicaid population over represented in overdose data About 30% of all drug-related deaths associated with methadone Misuse, abuse, and potentiating effects contribute to deaths 14

15 PDMP data reports Developed by a data work group consisting clinicians, research analysts, systems analysts, and pain and addiction specialists Consist of a statewide report and county-level reports for all 36 Oregon counties Distributed to local health officials and other key stakeholder groups Examine the most often prescribed controlled substances 15

16 Unique recipient count for opioids by age group, statewide, OR, 10/01/11 to 03/31/12 Age (in years) Prescription Recipient Count in 6 months dispensed in 6 months dispensed per prescription recipient in 6 months people receiving prescription, per 1,000 residents dispensed per 1,000 residents ,952 12, , , , , , , , , , , , , , , ,882 48, TOTAL 611,985 1,872, Opioids include: Hydrocodone, Oxycodone, Morphine, Methadone, Fentanyl, and Hydromorphone.

17 HYDROCODONE by age group, statewide, OR, 10/01/11 to 03/31/12 Age (in years) Prescription Recipient Count in 6 months dispensed in 6 months dispensed per prescription recipient in 6 months people receiving, per 1,000 residents dispensed per 1,000 residents ,442 10, ,183 72, , , , , , , , , , , ,679 63, ,331 27, TOTAL 438,275 1,030,

18 OXYCODONE by age group, statewide, OR, 10/01/11 to 03/31/12 Age (in years) Prescription Recipient Count in 6 months dispensed in 6 months dispensed per prescription recipient in 6 months people receiving, per 1,000 residents dispensed per 1,000 residents ,656 2, ,491 34, ,791 83, ,349 96, , , , , ,603 61, ,109 26, ,051 10, TOTAL 213, ,

19 METHADONE* by age group, statewide, OR, 10/01/11 to 03/31/12 Age (in years) Prescription Recipient Count in 6 months dispensed in 6 months dispensed per prescription recipient in 6 months people receiving, per 1,000 residents dispensed per 1,000 residents ,298 5, ,333 10, ,086 19, ,083 19, ,437 6, , TOTAL 14,268 64, *Does not include methadone used to treat addiction.

20 Unique recipient count for benzodiazepines by age group, statewide, OR, 10/01/11 to 03/31/12 Age (in years) Prescription Recipient Count in 6 months dispensed in 6 months dispensed per prescription recipient in 6 months people receiving prescription, per 1,000 residents dispensed per 1,000 residents ,042 5, ,747 34, , , , , , , , , , , ,173 64, ,758 28, TOTAL 315, , Benzodiazepines include: Alprazolam, Clonazepam, Diazepam, Lorazepam, Temazepam, and Zolpidem. *Cell sizes less than 10 for prescription recipient count have been suppressed.

21 Age (in years) OPIOID and BENZODIAZEPINE Combination by Age Group, Statewide, OR, 10/01/11 to 03/31/12 Prescription Recipient Count in 6 months dispensed in 6 months dispensed per prescription recipient in 6 months people receiving combination, per 1,000 residents dispensed per 1,000 residents ,642 13, ,336 54, ,700 79, , , , , ,148 53, ,862 24, ,855 11, TOTALS 108, , Opioids include: Hydrocodone, Oxycodone, and Morphine. Benzodiazepines include: Alprazolam, Clonazepam, Diazepam, and Lorazepam. Excludes Zolpidem that represents a chemically different class of benzodiazepine, and in which the risk of combination with opioids is thought to be somewhat lower.

22 How are these data reports helpful? Inform local health officials regarding prescribing practices in their areas Develop and implement population-based prevention approaches to reduce prescription drug overdose, such as public information campaigns and clinical guidance Target outreach Analyze the effects of overdose prevention efforts 22

23 Percentage of total CS II-IV written by prescriber cohort, OR, 1/1/12 to 9/30/12, N=49,330 21% of are written by the remaining 45,330 prescribers 19% of are written by a second cohort of 2,000 prescribers 60% of are written by a cohort of 2,000 prescribers* * Fifty-nine percent of these prescribers were authenticated system users as of 12/31/12

24 Sample: Methadone 10 mg tablet prescribing for XXXX County, Oregon, Jan 2012 Feb 2012 Mar 2012 Apr 2012 May 2012 Jun 2012 Jul 2012 Aug 2012 Sept 2012 Oct 2012 Nov 2012 Dec 2012 Recipient Count Rx Count 24

25 Additional use of PDMP data Better approximate exposure Greater potential to: Target risks Focus intervention efforts Tailor prevention programs Maximize therapeutic benefit to the population exposed 25

26 Selected drugs dispensed, statewide, OR, 10/1/2011 to 3/31/2012 Drug or drug type Prescription recipient count in 6 months dispensed to recipient in 6 months dispensed per prescription recipient in 6 months people receiving per 1,000 residents dispensed per 1,000 residents Methadone 14,268 64, Oxycodone 213, , Hydrocodone 438,275 1,030, All opiods 611,985 1,872,

27 Unintentional methadone and opioid overdose rate per 10,000 by exposure and population, OR, 2011 Count Crude rate/10,000 state population Crude rate/10,000 prescription recipients Methadone Hospitalizations Prescrip. Opioid Hospitalizations Methadone Deaths Prescrip. Opioid Deaths Sources: Oregon Vital Statistics and Hospital Discharge Index

28 Factors among decedents in methadone overdose, OR, N=56 41% had - 30% did not Misuse or abuse contributed to death in 77% History of substance abuse in 75% History of substance abuse treatment in 21% History of mental illness in 52% Source: Injury and Violence Prevention Program, Unpublished review of Oregon Medical Examiner data,

29 Why is methadone especially dangerous? For the same reason it is useful for treating pain: Long half-life Delayed onset Narrow therapeutic window Respiratory depression Cardiac arrest Interactions with other commonly used drugs Benzodiazepines Alcohol 29

30 Next steps Continue to look at exposure rates Support the PDMP data work group activities Examine acute versus chronic pain prescribing Analyze prescribing by discipline Explore how to measure system use Develop and support a local health department work group Analyze and revise data reports Explore practice guidelines Continue evaluation, quality assurance, and quality improvement activities 30

31 PDMP system accounts by discipline, OR, Sept 2011 to Dec 2012, N=5,270 PA 7% (353) ND 1% (31) RPh 17% (915) NP/CNS-PP 13% (682) DDS/DMD 6% (324) DO 5% (277) MD 51% (2,679)

32 Count PDMP queries by discipline, OR, Feb 2012 to Dec 2012, N=262, Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec ND DDS/DMD RPh 1,484 1,094 1,300 1,443 1,675 1,605 1,537 2,169 2,407 2,969 3,056 NP/CNS-PP 3,416 4,126 4,278 3,829 3,367 4,033 3,804 4,443 4,417 4,467 4,079 MD, PA, and DO) 15,484 14,638 15,861 17,149 17,456 18,804 17,838 19,558 19,286 18,693 17,921

33 Count Average monthly number of PDMP queries per querying user by discipline, OR, May 2012 to Dec May Jun Jul Aug Sept Oct Nov Dec ND DDS/DMD RPh NP/CNS-PP MD, PA, and DO

34 providers Distribution of queries per provider, OR, Jan 2012 to Dec ,800 1,600 1,400 1,200 1, queries

35 Program evaluation 2012 survey results: Overall positive - program shows promise Providers who strongly agreed or agreed that it would. likely improve management of patient for controlled substances - 92% likely engender interest for most providers and pharmacists for registering as users - 92% likely increase communication between providers 80% likely have an impact 82% 35

36 Survey result: Most registered users indicated that the program had been very helpful in: helping to monitor patients controlled substances (65%) helping to control doctor shopping (64%) 36

37 Survey result: Top reasons for using the system 1. Assess controlled substance use for patients who might be over using (86% of providers and 71% of pharmacists) 2. Assess controlled substance use of new patients (72% of providers and 59% of pharmacists) 37

38 Survey result: Actions taken after using system Spoke with a patient about controlled substance use - 78% Confirmed patient not misusing 68% Confirmed patient was doctor shopping 59% Reduced or eliminated for a patient 59% Contacted other providers or pharmacies 49% 38

39 Survey result: Increased communication About 2 in 3 system users reported increased communication as a result of system use with... Patients (79%) Providers who write (67%) Clinicians and staff inside my practice (64%) Pharmacists (63%) 39

40 Ongoing overdose prevention work 1. Enroll top cohort of prescribers 2. Engage local public health officials in efforts to increase use of prescribing guidelines and practice improvement 3. Disseminate controlled substance toolkit resource information health care system and community level interventions 4. Develop and disseminate a tool on use of PDMP reports with patients 40

41 Ongoing overdose prevention work 5. Explore how to better incorporate the PDMP into the clinical workflow 6. Improve information access for behavioral health treatment providers 7. Engage county substance abuse prevention specialists to disseminate public information 8. Work with health care systems and CCOs to integrate PDMP use into health care practice 41

42 Oregon PDMP Website Oregon PDMP reports can be found at 42

43 Questions? Todd Beran Oregon PDMP Coordinator Injury and Violence Prevention Program Public Health Division Oregon Health Authority

Oregon Prescription Drug Monitoring Program

Oregon Prescription Drug Monitoring Program Oregon Prescription Drug Monitoring Program 2013 Annual Report to the PDMP Advisory Commission PUBLIC HEALTH DIVISION Prescription Drug Monitoring Program Oregon Prescription Drug Monitoring Program 2013

More information

Presentation Objectives

Presentation Objectives Oregon s PDMP 101 Lisa Millet, MSH, Section Manager Injury and Violence Prevention Section Center for Prevention and Health Promotion Oregon Health Authority Eugene Oregon PDO Summit April 20, 2016 1 Presentation

More information

Prescription Drug Dispensing in Oregon

Prescription Drug Dispensing in Oregon Drug Dispensing in Oregon January 1, 2012 - December 31, 2012 Schedules II-IV Medications Dispensed in Oregon Linn County PUBLIC HEALTH DIVISION Drug Monitoring Program Drug Dispensing in Oregon: January

More information

Prescription Drug Dispensing in Oregon

Prescription Drug Dispensing in Oregon Drug Dispensing in Oregon October 1, 2011 March 31, 2012 Schedules II-IV Medications Dispensed in Oregon Jackson County PUBLIC HEALTH DIVISION Drug Monitoring Program Oregon Health Authority Public Health

More information

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division The Oregon Opioid Initiative State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division Disclosure No disclosures 2 Learning Objectives Learner will be able

More information

Prescription Opioid Overdose in Oregon: A public health perspective

Prescription Opioid Overdose in Oregon: A public health perspective Prescription Opioid Overdose in Oregon: A public health perspective Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Health Authority All-Cause Mortality,

More information

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Svetla Slavova, PhD Sara LaMantia, MS Terry Bunn, PhD Tracey Corey, MD 2016 Safe States Annual Meeting April 13, 2016, Albuquerque,

More information

Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015

Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015 Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015 1 Presenter Andrea Magermans Program Analyst of the Wisconsin PDMP Wisconsin Department of Safety and Professional

More information

Arkansas Prescription Monitoring Program

Arkansas Prescription Monitoring Program Arkansas Prescription Monitoring Program ONE YEAR UPDATE Scott Pace, Pharm.D., Esq. Special Thanks Thanks to Denise Robertson at the Arkansas Department of Health for supplying the PMP data for this presentation

More information

Prescription Drug Abuse: Developing Evidence-Based State Level Interventions

Prescription Drug Abuse: Developing Evidence-Based State Level Interventions Prescription Drug Abuse: Developing Evidence-Based State Level Interventions Signe Shackelford, MPH Policy Analyst APHA Annual Meeting November 5, 2013 Presenter Disclosure The following personal financial

More information

Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science

Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science National Center for Injury Prevention and Control Division of Analysis,

More information

Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD

Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD National Epidemic Highlighted numerous studies/media reports State Epidemic Highlighted

More information

New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) PDMP West Regional Meeting PMP Collaboration with the NM Department of Health April 26, 2018 New Mexico Board of Pharmacy Prescription

More information

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup Opioid Prescribing Metrics - DRAFT Definitions: Days Supply: The total of all opioid prescriptions dispensed during the calendar quarter

More information

PRESCRIBING GUIDELINES

PRESCRIBING GUIDELINES Ohio Department of Health RESPONSE TO OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC: PRESCRIBING GUIDELINES MIPA CONFERENCE PREVENTING INJURY: FROM RESEARCH TO PRACTICE TO PEOPLE SEPTEMBER 30, 2013 Christy

More information

COUNTY OF SAN DIEGO. Opioid Update

COUNTY OF SAN DIEGO. Opioid Update COUNTY OF SAN DIEGO Opioid Update Linda Bridgeman Smith, DUI & Prevention Services Manager Health & Human Services Agency, Behavioral Health Services Co-chair, Prescription Drug Abuse Task Force 1 HEADLINES

More information

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016 Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016 Prepared by: Robert G. Carlson, Ph.D., Professor and Director, Project Director Linna Li, M.S., Data Manager Raminta Daniulaityte,

More information

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A Prescription Drug Abuse Crises Outline 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A 1 1970s 1980s 2 The 1990s OXYCODONE Oxycodone/APAP OxyContin

More information

Opioid Overdose in Oregon Report to the Legislature

Opioid Overdose in Oregon Report to the Legislature SEPTEMBER 2018 Opioid Overdose in Oregon Report to the Legislature This report summarizes the burden of opioid overdose among Oregonians as required by ORS 432.141. It describes Oregon s progress in reducing

More information

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, -217 1, Total Overdose Deaths Male Female 8, 7,237 6, 4, 16,849 2 21 22 23 24 36,1 25 26 27 28 29 21 211 212 213 214 215 216 217-217

More information

Tom Williams, MD Chief Medical Officer Director of the Division of Public Health Nebraska Department of Health and Human Services

Tom Williams, MD Chief Medical Officer Director of the Division of Public Health Nebraska Department of Health and Human Services Tom Williams, MD Chief Medical Officer Director of the Division of Public Health Nebraska Department of Health and Human Services Helping People Live Better Lives Background DHHS dynamic agency Helping

More information

VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER

VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER To promote and protect the health of all Virginians Fatal Drug Overdose Quarterly Report Edition 216.3 Publication Date: January 217 METHODS,

More information

Controlled Substances Board

Controlled Substances Board Controlled Substances Board Report 1 July 1 September 30, 2016 Contact Information Wisconsin Controlled Substances Board Chairperson: Doug Englebert Members: Englebert, Doug, Chairperson Bloom, Alan, Vice

More information

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Heller School for Social Policy and Management Brandeis

More information

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and

More information

Montgomery County Poisoning Death Review:

Montgomery County Poisoning Death Review: Wright State University CORE Scholar Unintentional Prescription Drug Poisoning Project Center for Interventions, Treatment and Addictions Research 5-6-214 Montgomery County Poisoning Death Review: 21-213

More information

Controlled Substance Prescribing Trends and Odds of Drug Overdose Death

Controlled Substance Prescribing Trends and Odds of Drug Overdose Death Controlled Substance Prescribing Trends and Odds of Drug Overdose Death Christina Holt, MD, MSc 1, Kenneth McCall, PharmD 2 Gary Cattabriga, BA 3, Emily Bourret, PharmD 2, Chunhao Tu, PhD 2 ; Christian

More information

using analytics to identify and strategically manage patient opioid abuse

using analytics to identify and strategically manage patient opioid abuse using analytics to identify and strategically manage patient opioid abuse Philip Finocchiaro, MD, FACP Senior Medical Director, Quality and Clinical Outcomes Verscend Olivia Mapplethorpe Senior Client

More information

Drug-Related Deaths in Yolo County,

Drug-Related Deaths in Yolo County, Drug-Related Deaths in Yolo County, 2007-2015 May 2017 Authors: Ron Chapman, MD, MPH Haydee Dabritz, PhD Emma Middlemiss, MPH intern Yolo County Health & Human Services Agency (HHSA), Community Health

More information

Opioid Epidemic as it Relates to Counties

Opioid Epidemic as it Relates to Counties 89 TH ANNUAL WEST TEXAS COUNTY JUDGES AND COMMISSIONERS ASSOCIATION CONFERENCE Wednesday, April 25, 2018 11:05 11:55 a.m. Opioid Epidemic as it Relates to Counties Ms. Jessica Cance Agency Analytics Unit

More information

Opioid Overdose Education and Naloxone Distribution

Opioid Overdose Education and Naloxone Distribution Opioid Overdose Education and Naloxone Distribution Emily Stoukides, PharmD PGY-2 Ambulatory Care Pharmacy Resident Nicole Brunet, PharmD, BCPP Clinical Pharmacy Specialist, Mental Health Disclosures Emily

More information

Prescription Drug Abuse

Prescription Drug Abuse Prescription Drug Abuse Providers Need Drug Rehab Before They Can Lead Our Nation Into Recovery Roneet Lev, MD FACEP SCOPE OF PROBLEM Health Ledger 1979-2008 Oxycodone Hydocodone Diazepam (valium) Temazepam

More information

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director

More information

What is the strategy?

What is the strategy? What is the strategy? Multi-pronged approaches to reducing the health consequences of opioid use, New York City Northeast Epidemiology Conference Public health approach Track drug use and associated health

More information

Touchpoints Prior to Opioid Overdose Death

Touchpoints Prior to Opioid Overdose Death Touchpoints Prior to Opioid Overdose Death 7th Annual BU-CTSI Translational Science Symposium May 3, 2018 Marc Larochelle, MD, MPH Assistant Professor of Medicine Boston Medical Center and Boston University

More information

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for Responsible

More information

ANNUAL REPORT

ANNUAL REPORT ANNUAL REPORT - 2015 New Hampshire Prescription Drug Monitoring Program Report for July 1, 2014 June 30, 2015 Published October 2015 Table of Contents Executive Summary... 3-4 NH PDMP Background Information

More information

Poisoning Death Review Report. Montgomery County, 2017

Poisoning Death Review Report. Montgomery County, 2017 Poisoning Death Review Report Public Health Dayton & Montgomery County Prepared by Epidemiology Section Published May 15, 2018 Page 2 of 53 Contents Executive Summary... 5 Number of Drug Overdose... 5

More information

Managed Care Pushes for Safer Opioid Oversight

Managed Care Pushes for Safer Opioid Oversight Page 1 of 6 Clinical AUGUST 11, 2017 Managed Care Pushes for Safer Opioid Oversight High-risk pain Rx eyed Denver Health systems haven t escaped the nation s ongoing opioid crisis, as evidenced by surging

More information

Oregon Opioid Overdose Prevention Initiative

Oregon Opioid Overdose Prevention Initiative Oregon Opioid Overdose Prevention Initiative Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Association of Hospitals & Health Systems February 2017

More information

Michael M. Miller, MD, FASAM, FAPA

Michael M. Miller, MD, FASAM, FAPA Michael M. Miller, MD, FASAM, FAPA mmiller@rogershospital.org Medical Director, Herrington Recovery Center (HRC) Rogers Memorial Hospital Oconomowoc, Wisconsin Vice Speaker Wisconsin Medical Society Clinical

More information

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Heller School for Social Policy and Management Brandeis

More information

Opioid Data for Local Governments in North Carolina

Opioid Data for Local Governments in North Carolina Opioid Data for Local Governments in North Carolina Mary Beth Cox, Stacy Taylor, and Adam Lovelady October 10, 2018 Speakers Adam Lovelady Associate Professor UNC School of Government Mary Beth Cox Substance

More information

The Epidemiology of Opioid Abuse. Thomas Dobbs, MD, MPH Mississippi State Department of Health

The Epidemiology of Opioid Abuse. Thomas Dobbs, MD, MPH Mississippi State Department of Health The Epidemiology of Opioid Abuse Thomas Dobbs, MD, MPH Mississippi State Department of Health 1/12/2018 ACKNOWLEDGEMENTS DRUG ABUSE WORKING GROUP MISSISSIPPI STATE DEPARTMENT OF HEALTH Manuela Staneva,

More information

Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative

Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative John W. McIlveen, Ph.D., LMHC, State Opioid Treatment Authority, Oregon Health Authority, Addictions and Mental Health Division

More information

Na#onal Ins#tute for Health Care Management Founda#on Webinar

Na#onal Ins#tute for Health Care Management Founda#on Webinar Na#onal Ins#tute for Health Care Management Founda#on Webinar Blue Cross Blue Shield of Massachuse=s Opioid Safety Management Program Thomas Kowalski, RPh November 2, 2015 National and Local Concern National

More information

Montgomery County Poisoning Death Review

Montgomery County Poisoning Death Review Wright State University CORE Scholar Unintentional Prescription Drug Poisoning Project Center for Interventions, Treatment and Addictions Research Montgomery County Poisoning Death Review - Center for

More information

Kentucky All Schedule Prescription Electronic Reporting (KASPER)

Kentucky All Schedule Prescription Electronic Reporting (KASPER) Kentucky All Schedule Prescription Electronic Reporting (KASPER) Phyllis Millspaugh Manager, Behavioral Health Prevention and Promotion Kentucky Cabinet for Health and Family Services Using PDMP Data to

More information

Lisa Marzilli, PharmD, CDOE TOP 3 REASONS PEOPLE VISIT THEIR DOCTOR

Lisa Marzilli, PharmD, CDOE TOP 3 REASONS PEOPLE VISIT THEIR DOCTOR Lisa Marzilli, PharmD, CDOE TOP 3 REASONS PEOPLE VISIT THEIR DOCTOR 1 1. Skin disorders, including cysts, acne, and dermatitis. 2. Joint disorders, including osteoarthritis. 3. Back problems. Source: Mayo

More information

Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky

Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky Data Integration and Analysis for Improved Drug Overdose Surveillance in Kentucky Svetla Slavova, PhD Terry Bunn, PhD Bureau of Justice Assistance Research-Practitioner Partnership & Data-Driven Pilots

More information

Drug Overdose Deaths St. Louis County, Missouri

Drug Overdose Deaths St. Louis County, Missouri Drug Overdose Deaths St. Louis County, Missouri An overdose occurs when an excess and dangerous amount of a substance, such as alcohol, over thecounter medicine, prescription drugs, or illicit drug is

More information

AMCP Webinar Series. Responding to the Opioid Addiction Epidemic. July 29, Disclaimer

AMCP Webinar Series. Responding to the Opioid Addiction Epidemic. July 29, Disclaimer AMCP Webinar Series Responding to the Opioid Addiction Epidemic July 29, 2015 Disclaimer Organizations may not re use material presented at this AMCP webinar for commercial purposes without the written

More information

Opioid epidemic and PEHP

Opioid epidemic and PEHP Opioid epidemic and PEHP Agenda Overview of opioid crisis Utah perspective PEHP: clinical interventions Impact of interventions Why are we here? In the 1990s, the medical establishment came to believe

More information

Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data

Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data Presented to Bureau of Justice Assistance Harold Rogers Prescription

More information

Safe States Alliance 2018 Innovative Initiatives Finalist Summaries for Review

Safe States Alliance 2018 Innovative Initiatives Finalist Summaries for Review Safe States Alliance 2018 Innovative Initiatives Finalist Summaries for Review 1 Initiative #1: Aiming for Equity in Sexual Violence Prevention - Mapping Risks, Policies, Outcomes and Resources Statement

More information

Unintentional Drug Overdose Data Review

Unintentional Drug Overdose Data Review 28 Unintentional Drug Overdose Data Review Public Health - Dayton & Montgomery County Epidemiology Section May 2016 Page 1 of 26 Prepared by: Epidemiology Section of Public Health - Dayton & Montgomery

More information

Barbour County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report Barbour County

Barbour County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report Barbour County County West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report County The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with

More information

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Institute for Behavioral Health Schneider Institutes

More information

Mingo County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Mingo County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board

More information

Greenbrier County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Greenbrier County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board

More information

Overview of the Opioid Addiction Epidemic

Overview of the Opioid Addiction Epidemic Overview of the Opioid Addiction Epidemic Presenter: Dr. Andrew Kolodny Moderator: Cindy Rodgers Audio will begin at 3:00PM ET. You can listen through your computer speakers or call 866-835-7973 Meeting

More information

Putnam County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Putnam County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board

More information

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D. Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals

More information

Preventing Opioid Misuse in Texas

Preventing Opioid Misuse in Texas Preventing Opioid Misuse in Texas Kasey Strey, ACPS, SPF-Rx Project Director Jessica Duncan Cance, MPH, PhD, TTOR Lead Purpose Provide an overview of HHSC -funded opioid misuse prevention activities Discuss

More information

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN Pain Management and Safe use of opioids in hospitals Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN Bronx Care Health System Bronx Lebanon Hospital Concourse/ Fulton division, Nursing

More information

Drug Overdose Deaths, Hospitalizations, and Emergency Department Visits in Kentucky,

Drug Overdose Deaths, Hospitalizations, and Emergency Department Visits in Kentucky, Drug Overdose Deaths, Hospitalizations, and Emergency Department Visits in Kentucky, 2-212 Kentucky Injury Preven on and Research Center Drug Overdose Deaths, Hospitaliza ons, and Emergency Department

More information

Arizona State Office of Rural Health Webinar Series

Arizona State Office of Rural Health Webinar Series Arizona State Office of Rural Health Webinar Series Mute your phone &/or computer microphone Time is reserved at the end for Q&A Please fill out the post-webinar survey Webinar is being recorded Recording

More information

Oregon Opioid Prescribing Guidelines

Oregon Opioid Prescribing Guidelines Oregon Opioid Prescribing Guidelines Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Jim Rickards, MD, MBA Chief Medical Officer Oregon Health Authority Personal

More information

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 NAME OF GUIDELINE REASON FOR GUIDELINE WHAT THE GUIDELINE WILL ACHIEVE? WHO NEEDS TO KNOW ABOUT IT? Medicines Guideline: Hypnotic Medication Compliance with NICE

More information

Kanawha County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Kanawha County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board

More information

Pocahontas County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Pocahontas County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board

More information

CDC s Efforts to End the Opioid Epidemic

CDC s Efforts to End the Opioid Epidemic Amy Insert Peeples, CIO Name MPA Here Deputy Director, National Center for Injury Prevention and Control NCSL Opioid Policy Fellows Kick Off CDC s Efforts to End the Opioid Epidemic The Epidemic in America

More information

Figure 1: Quantity Dispensed/100 Members (Ambien and Sonata on left axis)

Figure 1: Quantity Dispensed/100 Members (Ambien and Sonata on left axis) Sedative Hypnotic Quantity Limit Policy Impact Analysis Effective 12/6/2 OMAP implemented a 15 tablet per 3 day quantity limit on non-barbiturate sedative hypnotics for FFS patients. This policy was made

More information

North Dakota Board of Pharmacy

North Dakota Board of Pharmacy North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives

More information

PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018

PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018 PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018 Contents Executive Summary... 2 User Registration & System Utilization... 4 Dispensation Rates... 6 Dispensation Rates by Geography... 6

More information

Six Building Blocks: Team-Based Opioid Management in Primary Care

Six Building Blocks: Team-Based Opioid Management in Primary Care Six Building Blocks: Team-Based Opioid Management in Primary Care Michael Parchman, MD, MPH Laura-Mae Baldwin MD, MPH Brooke Ike, MPH Mark Stephens, MA David Tauben, MD Funded by the Agency for Healthcare

More information

Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017

Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017 Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic October 25, 2017 Disclosures and Disclaimer Neither the Institute for Health Policy and Leadership (IHPL) nor I have any relevant financial

More information

ACCG Mental Health Summit

ACCG Mental Health Summit ACCG Mental Health Summit Sheila Pierce, Opioid Program Coordinator Director, Prescription Drug Management Program Discussion 1. Overview Opioid Problem in GA - Video 2. DPH Opioid Program 3. Priorities

More information

Opioid Prescription and Illicit Drug Overdoses: On the Rise

Opioid Prescription and Illicit Drug Overdoses: On the Rise Opioid Prescription and Illicit Drug Overdoses: On the Rise Cindy Haynes, MSA-PA, CHES Chronic Pain Program Coordinator Northern Piedmont Community Care Duke Division of Community Health Objectives Define

More information

Engaging Friends and Family to Prevent Prescription Opioid Misuse and Overdose Lessons Learned from Best Practice at the Local Level

Engaging Friends and Family to Prevent Prescription Opioid Misuse and Overdose Lessons Learned from Best Practice at the Local Level Engaging Friends and Family to Prevent Prescription Opioid Misuse and Overdose Lessons Learned from Best Practice at the Local Level NPN Conference Anaheim, CA September 13, 2017 Presentations Overview

More information

Opioids drive continued increase in drug overdose deaths

Opioids drive continued increase in drug overdose deaths CDC: Drug overdose deaths increase for 11th consecutive year Opioids drive continued increase in drug overdose deaths Atlanta, GA, USA (February 20, 2013) - Drug overdose deaths increased for the 11th

More information

Drug Overdose Deaths among Kentucky Residents, December, 2018

Drug Overdose Deaths among Kentucky Residents, December, 2018 Injury Prevention and Research Center Drug Overdose Deaths among Residents, 1999-217 December, 218 Prepared by David Akers MA, MS Peter Rock, MPH Svetla Slavova, PhD Terry L. Bunn, PhD Released by Injury

More information

Washington State PMP Data Mapping Project

Washington State PMP Data Mapping Project Washington State PMP Data Mapping Project 2014 Category 3 Grant Harold Rogers Category 3 Grantee Meeting February 25, 2015 Washington State BACKGROUND: OPIOID ISSUES AND PLANNING 2 WA Unintentional Opioid

More information

Opiate Use among Ohio Medicaid Recipients

Opiate Use among Ohio Medicaid Recipients Opiate Use among Ohio Medicaid Recipients July 12, 2012 Ohio Colleges of Medicine Government Resource Center The Ohio State University College of Public Health Sponsored by The Ohio Department of Alcohol

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics

More information

Poisonings Among Arizona Residents, 2010

Poisonings Among Arizona Residents, 2010 Poisonings Among Arizona Residents, 2010 Resources for the development of this report were provided through funding to the Arizona Department of Health Services from the Centers for Disease and Control

More information

The Morbidity and Mortality of Kansas Drug Epidemic

The Morbidity and Mortality of Kansas Drug Epidemic The Morbidity and Mortality of Kansas Drug Epidemic Fan Xiong, MPH Senior Epidemiologist Kansas Board of Pharmacy Kansas Data-Driven Prevention Initiative Program Kansas Department of Health and Environment,

More information

REB CLOSE, MD Community Hospital of the Monterey Peninsula

REB CLOSE, MD Community Hospital of the Monterey Peninsula REB CLOSE, MD Community Hospital of the Monterey Peninsula The Scope of the Problem 1-5 Opiate use in the US 80% of the world s prescription opiate supply 99% of the world s hydrocodone supply From 1997

More information

The Opioid Addiction Emergency In Virginia June 8, 2017

The Opioid Addiction Emergency In Virginia June 8, 2017 The Opioid Addiction Emergency In Virginia June 8, 2017 Marissa J. Levine, MD MPH State Health Commissioner Virginia Department of Health Chronic Disease of Addiction Definition: A primary, chronic disease

More information

PRESCRIPTION DRUG MONITORING PROGRAM

PRESCRIPTION DRUG MONITORING PROGRAM PRESCRIPTION DRUG MONITORING PROGRAM ST. LOUIS COUNTY Q2 2017 Contents Executive Summary... 2 User Registration & System Utilization... 4 Dispensation Rates... 6 Dispensation Rates by Geography... 6 Dispensation

More information

Ron Morton, M.A. Director of Recovery and Resiliency ValueOptions Tennessee

Ron Morton, M.A. Director of Recovery and Resiliency ValueOptions Tennessee Ron Morton, M.A. Director of Recovery and Resiliency ValueOptions Tennessee Copyright December 2010 1 The abuse of opiates and benzodiazepines has increased to a frightening degree nationally and in the

More information

Surveillance of Apparent Opioid Overdoses in New Brunswick

Surveillance of Apparent Opioid Overdoses in New Brunswick Surveillance of Apparent Opioid Overdoses in New Brunswick 7- Quarter 4 April, 8 Surveillance of apparent opioid overdoses in New Brunswick, 7 Q4 Page of Surveillance of Apparent Opioid Overdoses in New

More information

October 20, 2016 Scott K. Proescholdbell, MPH. Opioid Overdose and North Carolina s Public Health and Prevention Strategies

October 20, 2016 Scott K. Proescholdbell, MPH. Opioid Overdose and North Carolina s Public Health and Prevention Strategies October 20, 2016 Scott K. Proescholdbell, MPH Opioid Overdose and North Carolina s Public Health and Prevention Strategies Deaths per 100,000 population Death Rates* for Three Selected Causes of Injury,

More information

Opioid Prescribing Improvement Program

Opioid Prescribing Improvement Program Opioid Prescribing Improvement Program Jeff Schiff, MD, MBA, Medical Director of Minnesota Health Care Programs Sarah Rinn, MPH, Opioid Prescribing Improvement Program Coordinator Agenda Opioid Prescribing

More information

Medicare Advantage Outreach and Education Bulletin

Medicare Advantage Outreach and Education Bulletin Medicare Advantage Outreach and Education Bulletin Blue Cross and Blue Shield of Georgia Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain

More information

Carisoprodolol Quantity Limit Policy Impact Analysis

Carisoprodolol Quantity Limit Policy Impact Analysis Carisoprodolol Quantity Limit Policy Impact Analysis Carisoprodolol (Soma ) is a skeletal muscle relaxant that has deemed by many to have limited effectiveness for the treatment of acute musculoskeletal

More information

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Heller School for Social Policy and Management Brandeis

More information

Epi Data Tables. Benzodiazepines in New York City. Data Tables

Epi Data Tables. Benzodiazepines in New York City. Data Tables Epi Data Tables New York City Department of Health and Mental Hygiene June 2016, No. 72 Benzodiazepines in New York City Data Tables Table 1. Any self-reported benzodiazepine misuse in the past year, New

More information

OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC:

OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC: Cuyahoga County Board of Health OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC: NOVEMBER 5, 2014 CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS DEFINITIONS Opiate- originate from naturally-occurring elements

More information

PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health

PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health PDMP Track: Linking and Mapping PDMP Data Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health Disclosure Statement Gillian Leichtling and Chris Baumgartner have disclosed no

More information